Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 3, 2007, Pages 217-223

  Bianchi, Vera ^a   Maconi, Giovanni ^b   Ardizzone, Sandro ^b   Colombo, Elisabetta ^b   Ferrara, Elisa ^b   Russo, Antonio ^c   Tenchini, Maria Luisa ^a   Porro, Gabriele Bianchi ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Local Health Authority   (Italy)

Author keywords

Crohn's disease; Genotype phenotype correlation; NOD2 CARD15 mutations; Ulcerative colitis

Indexed keywords

ARGININE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; GLYCINE; LEUCINE; TRYPTOPHAN;

ADULT; APPENDECTOMY; ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; ITALY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; POPULATION GENETICS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 33847062913     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000250590.84102.12     Document Type: Article

References (25)

1. Ardizzone S, Bianchi Porro G. Inflammatory bowel disease: new insights into pathogenesis and treatment. J Int Med 2002; 252:475-496.
2. Zheng CQ, Hu GZ, Zeng ZS, Lin LJ, Gu GG. Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning. World J Gastroenterol 2003; 9:1646-1656.
3. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411:599-603.
4. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JPA. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse population: a metaanalysis. Am J Gastroenterol 2004; 99:2393-2404.
5. Palmieri O, Toth S, Ferraris A, Andriulli A, Latino A, Annese V, et al. CARD15 genotyping in inflammatory bowel disease patients by multiplex pyrosequencing. Clin Chem 2003; 49:1675-1679.
6. Vavassori P, Borgiani P, Biancone L, D'Apice MR, Blanco Gdel V, et al. CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease. Inflamm Bowel Dis 2004; 10:116-121.
7. Giachino D, van Duist MM, Regazzoni S, Gregori D, Bardessorio M, Salacone P, et al. Analysis of the CARD15 variants R702W, G908R and L1007fs in Italian IBD patients. Eur J Hum Genet 2004; 12:206-212.
8. Annese V, Lombardi G, Perri F, D'Inca R, Ardizzone S, Riegler G, et al. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease: an IG-IBD study. Am J Gastroenterol 2005; 100:84-92.
9. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347:417-429.
10. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6:8-15.
11. Ardizzone S, Colombo E, Maconi G, Bollani S, Manzionna G, Petrone MC, Bianchi Porro G. Infliximab in treatment of Crohn's disease: the Milan experience. Dig Liver Dis 2002; 34:411-418.
12. Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70:845-857.
13. Greenacre MJ. Theory and application of correspondence analysis. London: Academic Press; 1984.
14. Annese V, Latiano A, Andriulli A. Genetics of inflammatory bowel disease: the beginning of the end or the end of the beginning? Dig Liver Dis 2003; 35:442-449.
15. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411:603-606.
16. Vermeire S. NOD2/CARD15: relevance in clinical practice. Best Pract Res Clin Gastroenterol 2004; 18:569-575.
17. Russell RK, Nimmo ER, Satsangi J. Molecular genetics of Crohn's disease. Curr Opin Genet Dev 2004; 14:264-270.
18. Ahmad T, Armuzzi A, Bunce M, Mulcahy-Hawes K, Marshall SE, Orchard TR, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002; 122:854-866.
19. Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJ, et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 2002; 122:867-874.
20. Vermeire S, Louis E, Carbonez A, van Assche G, Norman M, Belaiche J, et al. Belgian group of infliximab expanded access programme in Crohn's disease. Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease. Am J Gastroenterol 2002; 97:2357-2363.
21. Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascheretti S, et al. Association of NOD2 (CARD15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 2002; 359:1661-1665.
22. Abreu MT, Taylor KD, Lin YC, Harg T, Gaiennie J, Landers CJ, et al. Mutation in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 2002; 123:679-688.
23. Heresbach D, Gicquel-Douabin V, Birebent B, D'halluin PN, Heresbach-Le Beurre N, Dreano S, et al. NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype-phenotype analysis. Eur J Gastroenterol Hepatol 2004; 16:55-62.
24. Mendoza JL, Murillo LS, Fernandez L, Pena AS, Lana R, Urcelay E, et al. Prevalence of mutations of the NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn's disease. Scand J Gastroenterol 2003; 38:1235-1240.
25. Binder V. Genetic epidemiology of inflammatory bowel disease. Dig Dis Sci 1999; 16:351-355.